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Atherosclerosis is the most frequent cause of extracranial
cerebrovascular disease, and represents an important cause
of stroke and transient ischemic attack, being responsible
for up to 15% to 20% of all ischemic strokes (1). Carotid
artery stenosis has long been recognized as an important
risk factor. In most studies of carotid artery stenosis inter-
vention, clinically important stenosis, beyond which point
the stroke risk is increased, are those greater than 50% to
60% diameter stenosis (2). Patients with asymptomatic ca-
rotid stenosis are at increased annual risk (2% to 5%) for
ipsilateral carotid territory ischemic stroke (3,4).See page 674However, although a clear correlation between the degree
of stenosis and the risk of stroke in symptomatic patients
was demonstrated in the NASCET trial (North American
Symptomatic Carotid Endarterectomy Trial) (5), this asso-
ciation was less clear in asymptomatic patients (6–10). In
fact, the pathophysiology of ipsilateral stroke in patients
with carotid artery stenosis goes far beyond the degree of
stenosis, with several other mechanisms involved: 1) artery-
to-artery embolism of thrombus formed on the atheroscle-
rotic plaque; 2) atheroembolism of cholesterol crystals or
other atheromatous debris; 3) acute thrombotic occlusion
of an extracranial artery resulting from plaque rupture; and
4) structural disintegration of the arterial wall resulting from
dissection or subintimal hematoma. Furthermore, reduced
cerebral perfusion resulting from critical stenosis or occlu-
sion caused by progressive plaque growth needs the intra-
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has received consultant fees from St. Jude Medical.symptoms to occur (1). This knowledge, along with data
from several randomized trials showing low rates of neuro-
logical events in asymptomatic patients with moderate-
to-severe carotid stenosis (8,9), point to the fact that the
degree of carotid stenosis is probably not the most important
measurement of interest, but rather the morphology and
composition of the carotid plaques are.
Therefore, other aspects of carotid lesions have been
explored as potential markers of plaque vulnerability and
stroke risk. Several noninvasive and invasive imaging mo-
dalities have shown the ability in small studies (11–13) to
characterize different plaque components and morphol-
ogies, such as positive remodeling, lipid content, ulceration,
echolucency, and intraplaque hemorrhage. However, the
prognostic value of such ﬁndings has yet to be determined
in prospective and adequately sized studies. Limited axial
resolution of these imaging methods also hampers the
identiﬁcation of some important aspects of plaque vulner-
ability (e.g., inﬂammation, ﬁbrous cap thickness, plaque
rupture, intraluminal thrombus) and contributes to the
difﬁcult task of identifying the so-called vulnerable carotid
plaques that would beneﬁt from invasive treatment, before
neurological events happen. As a result, symptomatic status
and severity of carotid stenosis still form the basis for
current guideline recommendations for carotid revascular-
ization (1).
In this issue of JACC: Cardiovascular Interventions, Jones
et al. (14) investigated carotid plaque characteristics with
intravascular optical coherence tomography (OCT) in 49
symptomatic (n ¼ 27) and asymptomatic (n ¼ 22) patients.
In this pioneering work, the authors take advantage of the
superior axial resolution of OCT (w10 mm) and expand
our knowledge of the carotid artery microenvironment, pro-
viding important insights regarding carotid stenosis quan-
tiﬁcation and plaque characterization. They also provide
reassuring information about the safety and feasibility of
performing OCT studies in the carotid circulation, acquiring
images of adequate quality for interpretation, with no need
of balloon occlusion or cerebral protection devices.
The accuracy of OCT for lumen quantiﬁcation has been
extensively described. In in vitro studies using phantom
models of known dimensions as references, OCT provided
lumen area measurements closer to the actual phantom
dimensions than did IVUS, and with less variability, posi-
tioning OCT as the most accurate modality for lumen
dimension quantiﬁcation in vivo.
In the coronary territory, quantitative angiography
underestimated lumen areas by about 5%, whereas IVUS
overestimated it by 9% when compared with OCT (15).
This slight variability can explain some of the results
presented by Jones et al. (14). Although a high correlation
was seen between the diameter stenosis measurements
derived by quantitative angiography and OCT (r ¼ 0.93,
p < 0.001), an unacceptably high variability (40%)
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686between the 2 methods was documented in cases where
revascularization decisions had been taken by angiography
or OCT. Based on the American Heart Association
(AHA) criteria for revascularization of 60% stenosis for
asymptomatic patients and 50% stenosis for symptom-
atic patients, 29% of the carotid lesions that would be
revascularized on the basis of angiographic quantiﬁcation
of stenosis severity would have their treatment deferred on
the basis of the OCT results; an additional 11% of the
lesions that would not be revascularized by angiography
would be treated on the basis of OCT quantiﬁcation.
These ﬁgures reinforce the limitations of angiography for
stenosis severity quantiﬁcation.
Furthermore, the authors conﬁrmed the stenosis–symptom
paradox, with asymptomatic individuals presenting greater
median diameter stenosis than symptomatic patients by
angiography (67% vs. 39%, p ¼ 0.004), with a trend in the
same direction by OCT (66% vs. 42%, p ¼ 0.098). Impor-
tantly, no correlations were observed between carotid diam-
eter stenosis and the presence of symptoms (p ¼ 0.10), even
after the exclusion of symptomatic patients with nonsigniﬁ-
cant carotid narrowings (p ¼ 0.33).
Beyond precise lumen quantiﬁcation, the high resolution
of OCT allows for accurate characterization of plaque
components, and identiﬁcation of features of plaque vul-
nerability such as lipid-rich plaques, ﬁbrous cap thickness,
thin-cap ﬁbroatheromas (TCFA), vascular inﬂammation,
plaque rupture, plaque erosion, and intravascular thrombus
(16–20). Beneﬁting from the unprecedented resolution of
OCT among all in vivo imaging modalities, Jones et al. (14)
elegantly used OCT to reproduce, in vivo, the AHA clas-
siﬁcation scheme of atherosclerosis derived from histopa-
thology, assessing carotid plaques for the presence of
“complicated” features known to be associated with adverse
clinical events: 1) ruptured TCFA; 2) intraluminal
thrombus; and 3) ruptured calciﬁed nodule. They found that
symptomatic patients had a signiﬁcantly higher frequency of
complicated plaques than asymptomatic patients (74.1% vs.
36.4%, p ¼ 0.02), with intraluminal thrombus (odds ratio:
3.49, 95% conﬁdence interval: 1.04 to 11.3, p ¼ 0.037) and
ruptured TCFA (odds ratio: 4.35, 95% conﬁdence interval:
1.03 to 18.3, p ¼ 0.045) emerging as independent predictors
of symptomatic status by logistic regression analysis. Inter-
estingly, complicated plaque features were evenly distributed
in stenoses smaller than or >50% by OCT. Another
important contribution from the current work is the report
that more than one-third of asymptomatic patients have
high-risk carotid plaques, potentially being at increased risk
of stroke, irrespective of stenosis severity. Once again, the
stenosis–symptoms paradigm has been challenged.
It is also important to highlight that most of the plaque
characteristics for classiﬁcation assessed in the current work
were assumed from histopathology validation of OCT
in coronary arteries. One should keep in mind thatatherosclerotic plaques in the carotid territory do not exhibit
the same composition and morphology as seen in coronary
arteries, likely as a consequence of different sizes, spatial
orientation, and ﬂow dynamics.
The main difference between carotid artery plaques and
coronary plaques is the higher prevalence of intraplaque
hemorrhage in the former: in symptomatic patients, 65%
of the carotid plaques showed signs of intraplaque hemor-
rhage (21). The prevalence of calciﬁcations is equivalent for
carotid and coronary plaques, although more calciﬁed nod-
ules were present in the carotid territory. From a mor-
phological perspective, carotid plaques often have smaller
necrotic cores and thicker ﬁbrous caps. Lumen cavities,
rarely seen in coronary arteries, are often observed in carotid
plaques, likely originating from a ruptured cap covering a
small necrotic core (22). The good news is that OCT can be
used to detect and quantify most of the compositional and
morphological characteristics of atherosclerotic plaques in
both the carotid and coronary circulation. As pointed out by
the investigators (14), intraplaque hemorrhage, an important
marker of plaque progression, may be difﬁcult to recognize
by OCT because of the light attenuation that makes dif-
ferentiation from lipid pools challenging. By contrast,
intimal microvessels, which have also been linked to coro-
nary plaque progression and may be a source for blood
extravasation and intraplaque hemorrhage, can be easily
identiﬁed by OCT, and serve as a potential indirect marker
of vulnerability.
As we reach the end of this journey into the carotid
microenvironment, we leave it with 1 certainty. Neurological
symptoms and risk of stroke are more to do with plaque
composition and morphology, rather than with the degree
of stenosis, which can serve, though, as an important marker
of disease burden. Lastly, this journey raises several doubts
that need to be further explored in future prospective studies:
what is the prognostic impact of such “complicated” plaques
detected by OCT? What is the ﬁbrous cap thickness that
best predicts carotid artery rupture? What is the best man-
agement strategy for these high-risk carotid plaques? What
is the risk of intervening (percutaneously or surgically) on
those lesions, and what plaques are going to beneﬁt most
from mechanical intervention?
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